Spur Therapeutics
Toward the next generation of gene therapy.
122 employees · est. 2015 · Stevenage, United Kingdom
Taysha Gene Therapies
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogenic diseases of the CNS.
134 employees · est. 2020 · Dallas, United States
Spur Therapeutics is the older company (2015 vs 2020).
Side-by-Side Comparison
| Metric | Spur Therapeutics | Taysha Gene Therapies |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2020 |
| Headquarters | ||
| Headquarters | Stevenage, United Kingdom | Dallas, United States |
| Employees | ||
| Employees | 122 | 134 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $260.50M | $802.30M |
| Funding Rounds | ||
| Funding Rounds | 7 | 9 |
| Services | ||
| Services | Not tracked yet | Development of Gene Therapies, Targeted Execution of Gene Therapy Programs, Research in Neurological and Genetic Disorders, Clinical Trial Management, Patient Support and Resources |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with CNS Diseases, Families and Caregivers of Patients, Healthcare Professionals, Investors in Biotech Industry |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Liver-directed, Inherited Diseases, Clinical Trials, AAV-based Therapy, Hemophilia B, Fabry Disease, Gaucher Disease, Haemophilia A, Innovation, Global Locations, Systemic Diseases, United Kingdom, United States | Gene Therapy, AAV-based Therapies, Monogenic Diseases, Central Nervous System, Rett Syndrome, Neurodevelopmental Disorders, Disease-modifying Therapies, AAV9 Capsid, Gene Therapy Development, Gene Therapy Commercialization, UT Southwestern Collaboration, Clinical-stage |
| Website | ||
| Website | spurtherapeutics.com | tayshagtx.com |
About Spur Therapeutics
Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options f...
About Taysha Gene Therapies
Taysha Gene Therapies, founded in 2020, is a promising clinical-stage biotechnology company headquartered in the United States. It specializes in developing adeno-associated virus (AAV)-based gene therapies specifically targeting severe monogenic diseases of the central nervous system (CNS). The co...
We will tell you when either one moves
BounceWatch watches Spur Therapeutics and Taysha Gene Therapies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Spur Therapeutics and Taysha Gene Therapies — by email.
Frequently Asked Questions
Compare Spur Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Spur Therapeutics on 11 Sep 2024, and Taysha Gene Therapies on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
